Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion
  • M&A / Deals

Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion

Big Molecule Watch

On April 22, 2026 Amneal Pharmaceuticals, Inc.

Read full story

pharminent May 4, 2026 (Last updated: May 5, 2026)

Big Molecule Watch

On April 22, 2026 Amneal Pharmaceuticals, Inc.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Part D Mail Order Prescription Drugs
Next: Cytospire hauls in $83M for a new type of T cell engager

Related Stories

  • M&A / Deals

J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout

pharminent July 31, 2026
  • M&A / Deals

Eisai and CORE Biomedicine agree on global licence for oncology pipeline

pharminent July 29, 2026
  • M&A / Deals

Argenx signs agreement to buy Forte Biosciences for $2.2bn

pharminent July 28, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.